The median interval from stroke to randomization was 15 days. During a mean follow-up of 2.5 years, the mean blood pressure was 3.8/2.0 mm Hg lower in the telmisartan group than in the placebo group.

Telmisartan was clearly not inferior to ramipril for both the prespecified primary outcome of death from cardiovascular causes, myocardial infarction, stroke, or hospitalization for heart failure ...

Telmisartan Study. The goal of this multicenter, multinational, randomized trial by Mann and colleagues was to assess the long-term renal effects of telmisartan vs placebo in adults at high ...

Telmisartan and angiotensin-converting enzyme inhibitors (ACEIs) are both effective and widely used antihypertensive drugs targeting renin–angiotensin–aldosterone system. The study aimed to ...

The results, from the Diabetics Exposed to Telmisartan and Enalapril (DETAIL) trial, were presented here today at the European Society of Cardiology Congress 2004. Prof Anthony H Barnett ...

Telmisartan, amlodipine; 40mg/5mg, 40mg/10mg, 80mg/5mg, 80mg/10mg; tabs. Take once daily. Initial therapy: 40/5mg or 80/5mg; may titrate at 2-week intervals to max 80/10mg. Add-on therapy: may be ...

Telmisartan, a drug widely used to help control blood pressure, may have uniquely potent activity in preventing stroke, according to a new study conducted in an animal model.

Telmisartan, an angiotensin II receptor type 1 blocker (ARB), was recently reported to promote lipolysis in mice by acting as a peroxisome proliferator-activated receptor (PPAR)-δ activator ...

Telmisartan, an angiotensin II receptor blocker, is indicated for the treatment of hypertension. Alembic Pharmaceuticals is recalling 1 lot of Telmisartan Tablets 20mg due to a complaint related ...

Alembic Pharmaceuticals pulled one lot of 30-count, 20 mg Telmisartan tablet bottles. A complaint said a bottle had 40 mg tablets of the hypertension medication.